World news, news around town, tech update 3
Ad
Tuesday, 10 April 2018
Mylan buys marketing rights to MS treatment from Israel's Mapi Pharma
(Reuters) - Drugmaker Mylan NV is acquiring global marketing rights to an experimental multiple sclerosis treatment from Israel's Mapi Pharma Ltd, the companies said on Tuesday.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment